Loading...
Market
How many countries will adopt the single-dose malaria vaccine by end of 2025?
2
Resolution / Starting Odds
Less than 10 • 25%
10 to 20 • 25%
21 to 30 • 25%
More than 30 • 25%
Reports from WHO or health ministries
Story
Single-Dose Malaria Vaccine Achieves 90% Protection in New Study Published in Nature Medicine by Seattle Children's and University of Washington
Jan 3, 2025, 03:16 PM
A recent study published in 'Nature Medicine' has revealed a breakthrough in malaria vaccination, demonstrating that a single-dose immunization using a genetically weakened whole malaria parasite vaccine can provide 90% protection against the disease. This development is part of ongoing research efforts to combat malaria, with the study being led by scientists from Seattle Children's and the University of Washington. Additionally, NIH researchers have identified a novel class of antibodies that targets a previously untapped portion of the malaria parasite, which could pave the way for new prevention strategies. These findings highlight significant advancements in malaria vaccine research and potential new avenues for treatment.
View original story
Similar markets
4-6 Countries • 25%
None • 25%
1-3 Countries • 25%
More than 6 Countries • 25%
5 to 10 countries • 25%
No countries • 25%
More than 10 countries • 25%
1 to 4 countries • 25%
More than 10 countries • 25%
6 to 10 countries • 25%
1 to 5 countries • 25%
No countries • 25%
81 to 120 countries • 25%
Less than 50 countries • 25%
50 to 80 countries • 25%
More than 120 countries • 25%
More than 15 million • 25%
10 million to 15 million • 25%
5 million to 10 million • 25%
Less than 5 million • 25%
1-5 million • 25%
5-10 million • 25%
Less than 1 million • 25%
More than 10 million • 25%
5-9 countries • 25%
15 or more countries • 25%
1-4 countries • 25%
10-14 countries • 25%
China • 25%
Brazil • 25%
India • 25%
South Africa • 25%